Literature DB >> 17131626

Vitreous fluid biomarkers.

Hideharu Funatsu1, Tetsuji Yamashita, Hidetoshi Yamashita.   

Abstract

Interactions between cells and the network of secreted proteins are associated with the ocular disease. In most cases, clinical appearcance is sufficiently diagnostic. However, in cases of nonspecific or atypical clinical presentation, diagnostic sampling of vitreous fluid can aid diagnosis and treatment for ocular disease. Progresses in the basic sciences, particularly molecular biology, and advances in surgical instrumentation have greatly enhanced the diagnostic armamentarium. These developments also have led to a better understanding of the pathophysiological processes involved in ocular diseases and have prompted evolution of new therapeutic modalities. In this chapter, we review techniques for vitreous fluid sampling and biomarker quantitation thereof. The molecular biology of bioactive vitreous fluid factors is also discussed with respect to their clinical involvement in the development of ocular disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17131626     DOI: 10.1016/s0065-2423(06)42004-7

Source DB:  PubMed          Journal:  Adv Clin Chem        ISSN: 0065-2423            Impact factor:   5.394


  7 in total

1.  Translational vitreous proteomics.

Authors:  Vinit B Mahajan; Jessica M Skeie
Journal:  Proteomics Clin Appl       Date:  2013-11-04       Impact factor: 3.494

2.  Differential accumulation of secreted AbetaPP metabolites in ocular fluids.

Authors:  Annamalai Prakasam; Anusuya Muthuswamy; Zsolt Ablonczy; Nigel H Greig; Abdul Fauq; Kosagisharaf Jagannatha Rao; Miguel A Pappolla; Kumar Sambamurti
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

3.  Activated VEGF receptor shed into the vitreous in eyes with wet AMD: a new class of biomarkers in the vitreous with potential for predicting the treatment timing and monitoring response.

Authors:  Geetanjali Davuluri; Virginia Espina; Emanuel F Petricoin; Mark Ross; Jianghong Deng; Lance A Liotta; Bert M Glaser
Journal:  Arch Ophthalmol       Date:  2009-05

4.  Elevated vitreous body glial fibrillary acidic protein in retinal diseases.

Authors:  Anselm Gerhard Maria Jünemann; Robert Rejdak; Cord Huchzermeyer; Ryszard Maciejewski; Pawel Grieb; Friedrich E Kruse; Eberhart Zrenner; Konrad Rejdak; Axel Petzold
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-08-18       Impact factor: 3.117

Review 5.  Proteomic Biomarkers of Retinal Inflammation in Diabetic Retinopathy.

Authors:  Hannah Youngblood; Rebekah Robinson; Ashok Sharma; Shruti Sharma
Journal:  Int J Mol Sci       Date:  2019-09-25       Impact factor: 5.923

Review 6.  Protein Biomarkers in Uveitis.

Authors:  Reema Bansal; Amod Gupta
Journal:  Front Immunol       Date:  2020-12-03       Impact factor: 7.561

7.  In-depth mass spectrometric mapping of the human vitreous proteome.

Authors:  Sebastian Aretz; Tim U Krohne; Kerstin Kammerer; Uwe Warnken; Agnes Hotz-Wagenblatt; Marion Bergmann; Boris V Stanzel; Tore Kempf; Frank G Holz; Martina Schnölzer; Jürgen Kopitz
Journal:  Proteome Sci       Date:  2013-05-20       Impact factor: 2.480

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.